These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 31368626)
1. From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs. McIntyre RL; Daniels EG; Molenaars M; Houtkooper RH; Janssens GE EMBO Mol Med; 2019 Sep; 11(9):e9854. PubMed ID: 31368626 [TBL] [Abstract][Full Text] [Related]
2. HDAC inhibitors: A new promising drug class in anti-aging research. Pasyukova EG; Vaiserman AM Mech Ageing Dev; 2017 Sep; 166():6-15. PubMed ID: 28843433 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic mechanisms underlying lifespan and age-related effects of dietary restriction and the ketogenic diet. Moreno CL; Mobbs CV Mol Cell Endocrinol; 2017 Nov; 455():33-40. PubMed ID: 27884781 [TBL] [Abstract][Full Text] [Related]
4. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target]. Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229 [TBL] [Abstract][Full Text] [Related]
5. Altered expression of histone deacetylases in cancer. Montezuma D; Henrique RM; Jerónimo C Crit Rev Oncog; 2015; 20(1-2):19-34. PubMed ID: 25746102 [TBL] [Abstract][Full Text] [Related]
6. Histone deacetylases as therapeutic targets--from cancer to cardiac disease. Abend A; Kehat I Pharmacol Ther; 2015 Mar; 147():55-62. PubMed ID: 25444758 [TBL] [Abstract][Full Text] [Related]
7. The effects of Rpd3 on fly metabolism, health, and longevity. Woods JK; Rogina B Exp Gerontol; 2016 Dec; 86():124-128. PubMed ID: 26927903 [TBL] [Abstract][Full Text] [Related]
8. Research Advances in the Use of Histone Deacetylase Inhibitors for Epigenetic Targeting of Cancer. Bai Y; Ahmad D; Wang T; Cui G; Li W Curr Top Med Chem; 2019; 19(12):995-1004. PubMed ID: 30686256 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs. Cantley MD; Haynes DR Inflammopharmacology; 2013 Aug; 21(4):301-7. PubMed ID: 23341163 [TBL] [Abstract][Full Text] [Related]
10. Role of histone deacetylases and their inhibitors in cancer biology and treatment. Beumer JH; Tawbi H Curr Clin Pharmacol; 2010 Aug; 5(3):196-208. PubMed ID: 20406169 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension. Chen F; Li X; Aquadro E; Haigh S; Zhou J; Stepp DW; Weintraub NL; Barman SA; Fulton DJR Free Radic Biol Med; 2016 Oct; 99():167-178. PubMed ID: 27498117 [TBL] [Abstract][Full Text] [Related]
12. The potential of HDAC inhibitors as cognitive enhancers. Gräff J; Tsai LH Annu Rev Pharmacol Toxicol; 2013; 53():311-30. PubMed ID: 23294310 [TBL] [Abstract][Full Text] [Related]
13. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors. Koppel I; Timmusk T Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482 [TBL] [Abstract][Full Text] [Related]